Modern lineages of Mycobacterium tuberculosis exhibit lineage-specific patterns of growth and cytokine induction in human monocyte-derived macrophages

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Sarkar, Rajesh ^a   Lenders, Laura ^a   Wilkinson, Katalin A ^a,d   Wilkinson, Robert J ^a,c,d   Nicol, Mark P ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12P40; TUMOR NECROSIS FACTOR;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CELL ISOLATION; CELL MATURATION; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MACROPHAGE; MONOCYTE DERIVED MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN INDUCTION; SOUTH AFRICA; TUBERCULOSIS;

CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-12 SUBUNIT P40; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84865087860     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043170     Document Type: Article

References (41)

1. WHO Tuberculosis global Factsheet (2010) World Health Organization. Available: http://www.who.int/mediacentre/factsheets/fs104/en/. Accessed 2012 May 15.
2. Gagneux S, Small PM, (2007) Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. The Lancet infectious diseases 7: 328-337.
3. Nicol MP, Wilkinson RJ, (2008) The clinical consequences of strain diversity in Mycobacterium tuberculosis. Transactions of the Royal Society of Tropical Medicine and Hygiene 102: 955-965.
4. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, et al. (2006) Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 103: 2869-2873.
5. Marais BJ, Victor TC, Hesseling AC, Barnard M, Jordaan A, et al. (2006) Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western cape province of South africa. Journal of Clinical Microbiology 44: 3539-3543.
6. Nicol MP, Sola C, February B, Rastogi N, Steyn L, et al. (2005) Distribution of strain families of Mycobacterium tuberculosis causing pulmonary and extrapulmonary disease in hospitalized children in Cape town, South africa. Journal of Clinical Microbiology 43: 5779-5781.
7. Comas I, Chakravartti J, Small PM, Galagan J, Niemann S, et al. (2010) Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nature Genetics 42: 498-503.
8. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN, (2002) Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends in Microbiology 10: 45-52.
9. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D, (2002) Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerging infectious diseases 8: 843-849.
10. Cowley D, Govender D, February B, Wolfe M, Steyn L, et al. (2008) Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape town, South africa. Clinical Infectious Diseases 47: 1252-1259.
11. Van der Spuy GD, Kremer K, Ndabambi SL, Beyers N, Dunbar R, et al. (2009) Changing Mycobacterium tuberculosis population highlights clade-specific pathogenic characteristics. Tuberculosis 89: 120-125.
12. Lopez B, Aguilar D, Orozco H, Burger M, Espitia C, et al. (2003) A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clinical & Experimental Immunology 133: 30-37.
13. Li Q, Whalen CC, Albert JM, Larkin R, Zukowski L, et al. (2002) Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model. Infection and Immunity 70: 6489-6493.
14. Theus SA, Cave MD, Eisenach KD, (2005) Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics. Journal of Infectious Diseases 191: 453-460.
15. Zhang M, Gong J, Yang Z, Samten B, Cave MD, et al. (1999) Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. Journal of Infectious Diseases 179: 1213-1217.
16. Rakotosamimanana N, Raharimanga V, Andriamandimby SF, Soares J-L, Doherty TM, et al. (2010) Variation in Gamma Interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar. Clinical Vaccine Immunology 17: 1094-1103.
17. Reed MB, Domenech P, Manca C, Su H, Barczak AK, et al. (2004) A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431: 84-87.
18. Sohn H, Lee KS, Kim SY, Shin DM, Shin SJ, et al. (2009) Induction of cell death in human macrophages by a highly virulent Korean isolate of Mycobacterium tuberculosis and the virulent strain H37Rv. Scandinavian journal of immunology 69: 43-50.
19. Tanveer M, Hasan Z, Kanji A, Hussain R, Hasan R, (2009) Reduced TNF-alpha and IFN-gamma responses to Central Asian strain 1 and Beijing isolates of Mycobacterium tuberculosis in comparison with H37Rv strain. Transactions of the Royal Society of Tropical Medicine and Hygiene 103: 581-587.
20. Wang C, Peyron P, Mestre O, Kaplan G, van Soolingen D, et al. (2010) Innate immune response to Mycobacterium tuberculosis Beijing and other genotypes. PloS One 5: e13594.
21. Gascoyne-Binzi DM, Barlow REL, Essex A, Gelletlie R, Khan MA, et al. (2002) Predominant VNTR family of strains of Mycobacterium tuberculosis isolated from South Asian patients. The International Journal of Tuberculosis and Lung Disease 6: 492-496.
22. Newton SM, Smith RJ, Wilkinson KA, Nicol MP, Garton NJ, et al. (2006) A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proceedings of the National Academy of Sciences 103: 15594-15598.
23. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, et al. (2006) Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. Bio Med Central Microbiology 6: 23.
24. Zhang M, Gong J, Lin Y, Barnes PF, (1998) Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infection and immunity 66: 794-799.
25. Tsolaki AG, Gagneux S, Pym AS, Goguet de la Salmoniere Y-OL, Kreiswirth BN, et al. (2005) Genomic Deletions Classify the Beijing/W Strains as a Distinct Genetic Lineage of Mycobacterium tuberculosis. Journal of clinical microbiology 43: 3185-3191.
26. Hoal-van Helden EG, Hon D, Lewis LA, Beyers N, van Helden PD, (2001) Mycobacterial growth in human macrophages: variation according to donor, inoculum and bacterial strain. Cell Biology International 25: 71-81.
27. Wong KC, Leong WM, Law HKW, Ip KF, Lam JTH, et al. (2007) Molecular characterization of clinical isolates of Mycobacterium tuberculosis and their association with phenotypic virulence in human macrophages. Clinical Vaccine Immunology 14: 1279-1284.
28. Torrelles JB, Knaup R, Kolareth A, Slepushkina T, Kaufman TM, et al. (2008) Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan. Journal of Biological Chemistry 283: 31417-31428.
29. Schlesinger L, (1993) Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. The Journal of Immunology 150: 2920-2930.
30. Gordon S, Taylor PR, (2005) Monocyte and macrophage heterogeneity. Nature Reviews Immunology 5: 953-964.
31. Cooper AM, Solache A, Khader SA, (2007) Interleukin-12 and tuberculosis: an old story revisited. Current opinion in immunology 19: 441-447.
32. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, et al. (1998) Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280: 1432-1435.
33. Altare F, Ensser A, Breiman A, Reichenbach J, Baghdadi JE, et al. (2001) Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis. The Journal of Infectious Diseases The Journal of infectious diseases 184: 231-236.
34. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, et al. (2001) Tuberculosis associated with Infliximab, A factor α- neutralizing agent. New England Journal of Medicine 345: 1098-1104.
35. Mankia S, Peters J, Kang S, Moore S, Ehrenstein M, (2011) Tuberculosis and anti-TNF treatment: experience of a central London hospital. Clinical Rheumatology 30: 399-401.
36. Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, et al. (2010) The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. European Respiratory Journal 36: 1185-1206.
37. Hirsch CS, Yoneda T, Averill L, Ellner JJ, Toossi Z, (1994) Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by Transforming growth factor-β. Journal of Infectious Diseases 170: 1229-1237.
38. Portevin D, Gagneux S, Comas I, Young D, (2011) Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathogens 7: e1001307.
39. Manca C, Reed MB, Freeman S, Mathema B, Kreiswirth B, et al. (2004) Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infection and Immunity 2004/08/24 ed pp. 5511-5514.
40. Manca C, Tsenova L, Barry CE III, Bergtold A, Freeman S, et al. (1999) Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. Journal of immunology 162: 6740-6746.
41. Lasunskaia E, Ribeiro SCM, Manicheva O, Gomes LL, Suffys PN, et al. (2010) Emerging multidrug resistant Mycobacterium tuberculosis strains of the Beijing genotype circulating in Russia express a pattern of biological properties associated with enhanced virulence. Microbes and Infection 12: 467-475.